CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors
2015 · mAbs · 44 citations
https://doi.org/10.1080/19420862.2015.1119352
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
577
Citations
7
h-index
6
i10-index
Veronika Rayzman is an academic researcher from CSL (United Kingdom). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Coagulation, Bradykinin, Polyphosphates, and Angioedema & Glycosylation and Glycoproteins Research. The author has an h-index of 7, co-authored 10 publications.
ORCID: 0000-0001-9268-8305Click to start Chat